Also, it has been shown that when combining tau with an AD marker such as Aβ(1-42), cognitive decline can be predicted (Hansson et al., 2018), meaning that ratios might be better at predicting progression, although the biological reasoning behind and interpretation of these ratios need to be defined more clearly. The gene discussed is MAPT; the disease is Alzheimer disease.